Biodesix is a data-driven diagnostic solutions company utilizing technologies with its proprietary artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. In addition to diagnostic tests, Co. provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. Co.'s diagnostic blood-based tests across the lung cancer continuum of care include: Nodify XL2® and Nodify CDT® tests, which assess the risk of lung cancer to help identify the appropriate treatment pathway. We show 15 historical shares outstanding datapoints in our coverage of BDSX's shares outstanding history.
Understanding the changing numbers of BDSX shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like BDSX versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching BDSX by allowing them to research BDSX shares outstanding history
as well as any other stock in our coverage universe. |
Free BDSX Email Alerts:
Video: Shares Outstanding Importance
